Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
All articles
Showing 397–408 of 411 articles
- Understand the science
What blocking two muscle signals changed in an early human trial
Trevogrumab is an investigational monoclonal antibody against myostatin, also known as GDF8. An older phase 1 trial investigated the effects of blocking myostatin and a second signal called activin A, separately and together. The trial had two parts.
Trevogrumab2 sources (2024–2026)
- Check methods and identity
How animal studies tested muscle and fat during weight change
Trevogrumab is an investigational monoclonal antibody that blocks myostatin. An older study in male mice and nonhuman primates examined what happened to lean tissue and fat when investigators blocked myostatin and activin A during treatment with a GLP-1 receptor agonist.
Trevogrumab2 sources (2024–2026)
- Check methods and identity
What an older sarcopenia trial measured with a body scan
Trevogrumab, also called REGN1033 in earlier studies, is a larger investigational antibody that blocks myostatin. An older randomized study in people with sarcopenia tested whether the antibody changed lean body mass over 12 weeks.
Trevogrumab3 sources (2013–2026)
- Explore study findings
The prostate cancer trial that holds triptorelin constant
Triptorelin is a synthetic ten-amino-acid version of gonadotropin-releasing hormone, or GnRH. With sustained exposure it lowers testosterone, and the U.S. prescribing label for Trelstar identifies advanced prostate cancer as its approved use.
Triptorelin GnRH2 sources (2026)
- Explore study findings
What changed when an IVF trial added triptorelin to hCG?
Triptorelin acetate contains a synthetic ten-amino-acid mimic of gonadotropin-releasing hormone, or GnRH.
Triptorelin GnRH3 sources (2025, 2026)
- Check methods and identity
Two triptorelin formulations compared in girls with early puberty
Triptorelin is a ten-amino-acid synthetic agonist of the receptor for gonadotropin-releasing hormone, or GnRH. Sustained exposure reduces pituitary hormone output.
Triptorelin GnRH2 sources (2025, 2026)
- Explore study findings
What longer follow-up adds to triptorelin research in early puberty
Triptorelin is a synthetic ten-amino-acid agonist of the receptor for gonadotropin-releasing hormone, or GnRH. An extended-release U.S. product, Triptodur, is approved for central precocious puberty in children age two and older.
Triptorelin GnRH2 sources (2025, 2026)
- Check methods and identity
How an endometriosis study tested two triptorelin preparations
Triptorelin is a synthetic ten-amino-acid agonist of the receptor for gonadotropin-releasing hormone, or GnRH. Sustained exposure can lower ovarian estrogen production.
Triptorelin GnRH3 sources (2025, 2026)
- Check methods and identity
How triptorelin was tested for sustained testosterone suppression
Triptorelin is a synthetic ten-amino-acid mimic of gonadotropin-releasing hormone, or GnRH. Sustained exposure reduces pituitary signaling to the testes and lowers testosterone.
Triptorelin GnRH2 sources (2009, 2026)
- Understand the science
What Melanotan II Revealed About Appetite Signaling in Mice
Melanotan II is a synthetic peptide modeled on a natural melanocortin signal. It activates several melanocortin receptors. A September 2026 study used it to test how one of those receptors, MC4R, helps control feeding in mice. The researchers studied attractin-like protein 1, known as ATRNL1.
Melanotan II2 sources (2026)
- Understand the science
How Oral Pigmentation Changed Over Three Months
Melanotan II mimics part of a natural melanocortin signal that can stimulate pigment-producing cells. In 2026, dentist Alexander Bonchev reported how the color of one patient's gums and inner cheeks changed during reported Melanotan II exposure and over three months of follow-up.
Melanotan II3 sources (2025, 2026)
- Explore study findings
What Five Skin Biopsies Showed After Reported Melanotan Exposure
Melanotan II is a synthetic peptide that can activate those receptors. A 2026 dermatology case report described five melanomas found after a patient noticed that several existing moles had darkened during a period of reported melanotan use and indoor tanning.
Melanotan II1 source (2026)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
